Faron Pharmaceuticals is a biopharmaceutical company developing treatments for medical conditions with unmet needs. It offers Clevegen, an anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease, and vaccine development.